Today: 19 May 2026
Browse Category

TSX:4523 30 August 2025 - 12 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Japan Stock Market Today: Nikkei 225 Ends Flat as SoftBank Crashes on AI Jitters – November 25, 2025

Japan Stock Market Today: Nikkei 225 Ends Flat as SoftBank Crashes on AI Jitters – November 25, 2025

SoftBank Group shares plunged 9.95% in Tokyo on Tuesday, erasing most of the Nikkei 225’s early gains and wiping an estimated 338 points from the index. The Nikkei closed up just 0.07% at 48,659.52 after surging more than 1% at the open, while the Topix slipped 0.21%. Turnover on the Topix was above the three-month average.
25 November 2025
·········
Science Shockers: AI-Created Viruses, “Water Worlds” Debunked & More (Sept 19–20, 2025)

Science Shockers: AI-Created Viruses, “Water Worlds” Debunked & More (Sept 19–20, 2025)

Researchers used AI to design the first viruses from scratch, creating bacteriophages that killed drug-resistant bacteria. Scientists solved why smoking affects ulcerative colitis and Crohn’s disease differently, linking it to mouth bacteria. New Alzheimer’s drugs modestly slowed disease in early stages. Wildfire smoke could kill 70,000 Americans annually by 2050, Stanford researchers warned.
20 September 2025
·····
Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

The FDA approved Leqembi IQLIK, the first at-home injectable Alzheimer’s treatment, enabling weekly self-administered doses. U.S. regulators also cleared Sanofi’s Wayrilz, the first BTK inhibitor for chronic immune thrombocytopenia. Cytokinetics’ aficamten outperformed metoprolol in a Phase 3 heart drug trial. WHO warned Gaza has run out of critical medical supplies amid a spike in Guillain-Barré syndrome cases.
30 August 2025
····

Stock Market Today

  • Fuller, Smith & Turner PLC Completes Share Buyback Driving Treasury Shares Higher
    May 19, 2026, 3:15 PM EDT. Fuller, Smith & Turner PLC (FSTA) bought 7,504 of its own "A" Ordinary Shares at an average price of 630 pence per share on May 19, 2026, through Deutsche Bank's trading arm, Deutsche Numis, continuing its share buyback programme launched in January 2026. The total listed issued shares now stand at 36.45 million, with 5.31 million shares held in Treasury. Treasury shares are those that the company repurchases and holds rather than canceling, often to support share prices or for future use. This latest transaction adjusts the total voting rights to 31.14 million shares, as per FCA rules on Disclosure and Transparency. Fuller's plans to retain the repurchased shares in Treasury as part of its ongoing capital management strategy.

Latest articles

Marvell Stock Is Jumping Again — The AI Chip Trade Has One Week To Prove It

Marvell Stock Is Jumping Again — The AI Chip Trade Has One Week To Prove It

19 May 2026
Marvell shares climbed 6.6% to $180.04 Tuesday, outperforming a falling Nasdaq as investors positioned ahead of its May 27 earnings call. Trading volume reached 15.3 million shares, with the company’s market value near $155.5 billion. The stock’s rally followed analyst price target hikes and speculation over AI data-center demand. Marvell last reported record annual revenue and forecast further growth led by its data-center business.
Enbridge Stock Hits a 52-Week High Even as Line 5 Fight Throws Up a Fresh Risk

Enbridge Stock Hits a 52-Week High Even as Line 5 Fight Throws Up a Fresh Risk

19 May 2026
Enbridge Inc. shares hit a 52-week high of C$78.25 on Tuesday, rising 2.76% even as the S&P/TSX Composite slipped 0.1% amid inflation concerns. The move came after the company reaffirmed 2026 financial guidance and despite a partial construction pause on its Line 5 project in Wisconsin. Pembina Pipeline shares also rose, though less sharply.
Amazon shares fall as $200 billion AI question lingers

Amazon shares fall as $200 billion AI question lingers

19 May 2026
Amazon shares fell 2.3% to $258.73 Tuesday, underperforming the S&P 500 and Nasdaq as investors trimmed tech holdings ahead of Nvidia’s earnings. AWS revenue jumped 28% to $37.6 billion last quarter, but Amazon’s free cash flow dropped to $1.2 billion over the past year from $25.9 billion, reflecting heavy AI spending.
Go toTop